GOLDMAN SACHS GROUP INC - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 117 filers reported holding IMMUNOVANT INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$19,595,791
+217.6%
510,440
+56.9%
0.00%
+300.0%
Q2 2023$6,169,916
-9.8%
325,246
-26.2%
0.00%0.0%
Q1 2023$6,837,708
+3.8%
440,858
+18.8%
0.00%0.0%
Q4 2022$6,589,652
+1564.1%
371,248
+422.4%
0.00%
Q3 2022$396,000
-58.5%
71,069
-71.0%
0.00%
Q2 2022$955,000
-51.3%
244,952
-31.1%
0.00%
Q1 2022$1,960,000
-21.7%
355,694
+21.0%
0.00%
Q4 2021$2,503,000
-37.3%
293,849
-36.0%
0.00%
-100.0%
Q3 2021$3,989,000
+83.4%
458,973
+123.1%
0.00%
Q2 2021$2,175,000
-87.0%
205,734
-80.3%
0.00%
-100.0%
Q1 2021$16,784,000
-53.8%
1,046,381
+33.0%
0.00%
-55.6%
Q4 2020$36,340,000
+737.5%
786,755
+538.1%
0.01%
+800.0%
Q3 2020$4,339,000
+18.4%
123,301
-18.1%
0.00%0.0%
Q2 2020$3,666,000
+219.1%
150,537
+103.9%
0.00%
Q1 2020$1,149,00073,8420.00%
Other shareholders
IMMUNOVANT INC shareholders Q3 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,510,412$264,291,0006.36%
Ghost Tree Capital, LLC 525,000$18,475,0005.34%
Pinz Capital Management, LP 199,100$7,006,0002.56%
ACUTA CAPITAL PARTNERS, LLC 250,000$8,798,0002.39%
BVF INC/IL 1,198,427$42,173,0002.30%
Cormorant Asset Management, LP 1,637,951$57,639,0002.22%
Vivo Capital, LLC 1,042,460$36,684,0002.12%
Parkman Healthcare Partners LLC 150,151$5,284,0001.40%
MANGROVE PARTNERS IM, LLC 230,307$8,105,0001.02%
Ikarian Capital, LLC 321,887$11,328,0000.82%
View complete list of IMMUNOVANT INC shareholders